FANCA and Friedreich ataxia: The diagnosis of FA is based on the combination of typical clinical symptoms and the characteristic hypersensitivity of cells from affected patients to the ICL reagents diepoxybutane (DEB), mitomycin C (MMC), melphalan or cisplatin, which often are used to dissect the functions of individual FA proteins (18,26).